- A Randomized, Placebo-Controlled Study of a New Sublingual Formulation of Fentanyl Citrate (Fentanyl Ethypharm) for Breakthrough Pain in Opioid-Treated Patients With Cancer2014 | First Faculty of Medicine
- Sublingual fentanyl - a new opioid dosage form for breakthrough pain therapy2011 | First Faculty of Medicine, Third Faculty of Medicine
- Guideline for the treatment of breakthrough cancer pain2011 | Second Faculty of Medicine
- Fentanyl nasal spray2011 | Third Faculty of Medicine